MPM.L Regulatory News (MPM)

2 Jul 2007 16:13

Minster Pharmaceuticals PLC02 July 2007 Minster Pharmaceuticals PLC 2 July 2007 Minster Pharmaceuticals PLC (the 'Company') Rule 5.1.2 Notification The Company was notified on 29 June 2007 by MKM Longboat Capital Advisors LLP ofthe following acquisition of a major shareholding in the Company. The disclosurewas made in accordance with Disclosure and Transparency Rule 5.1.2. Date of transaction 27 March 2007 Threshold crossed 4% Type of shares: GB00B142W462 After the triggering transaction, MKM Longboat Multi-Strategy Master FundLimited indirectly holds 2,769,150 shares in the Company and indirectly holds2,769,150 voting rights in the Company. Accordingly MKM Longboat Multi-StrategyMaster Fund Limited indirectly holds 4.70% of the voting rights in the Company. Persons subject to the notification obligations:- MKM Longboat Multi-Strategy Master Fund LimitedMKM Longboat Multi-Strategy Fund LimitedMKM Longboat Capital Advisors LLPMKM Longboat Capital Advisors (UK) LimitedMKM Longboat Capital Advisors (Cayman) Limited MKM Longboat Multi-Strategy Master Fund Limited is the beneficial holder of theshares. MKM Longboat Multi-Strategy Fund Limited is a parent undertaking of MKMLongboat Multi-Strategy Master Fund Limited. MKM Longboat Capital Advisors LLP is a discretionary investment manager of MKMLongboat Multi-Strategy Master Fund Limited. MKM Longboat Capital Advisors LLPis managed by MKM Longboat Capital Advisers (UK) Limited.MKM Longboat Capital Advisors (Cayman) Limited is a parent undertaking of MKMLongboat Capital Advisors (UK) Limited. The full name of the registered shareholder is Goldman Sachs International,which holds the shares as a nominee for MKM Longboat Multi-Strategy Master FundLimited. Name of contact and telephone number for enquiries: Jeremy Gorman, Company Secretary Tel: 020 7935 0027 2 July 2007 This information is provided by RNS The company news service from the London Stock Exchange